Daniel Mark Schwartz - 29 Jul 2021 Form 3 Insider Report for RxSight, Inc. (RXST)

Reporting relationship: Director
Issuer ticker: RXST
Reported as of: 29 Jul 2021
Net transaction value: $0
SEC form: 3
Accepted by SEC: 29 Jul 2021, 10:49:19 UTC
Next SEC filing: 05 Aug 2021
Source filing: View source filing
Reporting owner signature: /s/ Shelley Thunen, as Attorney-in-Fact

Filing notes and source

Key filing fact

Daniel Mark Schwartz filed Form 3 for RxSight, Inc. (RXST) on 29 Jul 2021.

Key facts

This page summarizes Daniel Mark Schwartz's Form 3 filing for RxSight, Inc. (RXST).
0 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 29 Jul 2021, 10:49.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RXST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 414,690
Date: 29 Jul 2021
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RXST holding Derivative

Series C Preferred Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 29 Jul 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,872
Exercise price
Footnotes: F1

RXST holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 29 Jul 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,840
Exercise price: $4.14
Footnotes: F2

RXST holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 29 Jul 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,260
Exercise price: $4.14
Footnotes: F2

RXST holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 29 Jul 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,904
Exercise price: $4.14
Footnotes: F2

RXST holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 29 Jul 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 179,038
Exercise price: $3.93
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer will automatically be converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") prior to the closing of the Issuer's initial public offering of its Common Stock.

Footnote F2

Shares issued pursuant to the Issuer's 2006 Stock Plan.

Footnote F3

Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .